Updated Open-Label Extension Clinical Data and New Magnetization Transfer Ratio Imaging Data From a Phase I Study of ATA188, an Off-the-Shelf, Allogeneic Epstein-Barr Virus-Targeted T-Cell Immunotherapy for Progressive Multiple Sclerosis
MULTIPLE SCLEROSIS JOURNAL(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要